Ian Pavelich (Dunham Group) has been awarded an Advancing Science in America or ARCS Fellowship. The ARCS Foundation advances science and technology in the United States by providing financial awards to academically outstanding U.S. citizens studying to complete degrees in science, engineering and medical research. The awards are focused on helping researchers at the startup or “seed stage” of their work and discovery.
Ian’s project is titled “Molecular mechanisms of antibiotic tolerance.” “The project focuses on identifying the molecular mechanism for how pathogenic bacteria confer an antibiotic tolerance phenotype or behavior without the requirement for genetic mutations,” says Ian. “Currently, we’re attempting to identify how different stresses, like classes of antibiotics, activate different enzymes that trigger antibiotic tolerance.” The research has potential implications for the future of public health: “As modern medicine would be impossible without the use of antibiotics, further investigating these novel systems as potential new antimicrobial strategies is incredibly important.”
The ARCS Award is an unrestricted $7,500 award given directly to the scientist and may be renewed for up to three years. When asked how the ARCS Award will affect his work, Ian says: “I think that ARCS will provide a layer of flexibility in how we choose to answer the questions targeted by my research. I am extremely grateful that the ARCS committee granted me these funds, and with them I aim to expand the scope of my studies using more interdisciplinary approaches. I also plan to use funds to attend a range of diverse conferences.”
Outside the lab, Ian has been involved in outreach at Emory, working on a chemistry event during the annual Science Olympiad for area high school students that focused on fundamental gas laws and their quantitative uses. Ian’s ties to Emory go beyond chemistry, too. This month, his partner will be joining the Political Science Department graduate program at Emory: “we’ll be doing our PhDs side by side!”